Background. We aimed to clarify the relationship between HLA-DRB1
Introduction
Human leukocyte antigen (HLA), which plays an important role in immune responses, consists of the class I and class II molecules. Class I molecules, which are composed of a heavy chain encoded by the HLA-A, HLA-B or HLA-C genes and a light chain such as β2-microglobulin, react with peptides that are 8 or 9 amino acids in length. Class II molecules, including the DR (α chain encoded by DRA and β chain encoded by DRB), DQ (DQA and DQB) and DP (DPA and DPB) subtypes, bind to peptides ∼15 amino acids in length. Class II molecules, expressed on antigenpresenting cells, contribute to the production of specific antibodies.
Anti-glomerular basement membrane (GBM) antibodies, which are found in individuals with crescentic glomerulonephritis or Goodpasture's disease, react with the type IV collagen α3 NC1 domain [α3(IV)NC1]. Although the relationship between anti-GBM antibodies and HLA-DR15 has been examined in Caucasians [1] [2] [3] [4] [5] [6] [7] , there are no data examining HLA phenotypes and genotypes of patients with anti-GBM antibody-mediated disease in Japan or other areas of Asia. The present study was designed to clarify the importance of the HLA DR 15 and HLA-DRB1 alleles in Japanese patients with anti-GBM antibody-mediated disease.
Materials and methods
Samples were collected from 16 patients admitted to our department or related hospitals from December 1990 to October 2005 that were positive for anti-GBM antibodies. We analysed clinical and laboratory data, kidney biopsy findings, and the HLA-DR haplotypes and genotypes after obtaining informed consent from each patient.
We used chi-square analysis with Yates' correction to analyse allele frequencies of DRB1 in patients with anti-GBM antibody-mediated disease compared with Japanese controls (561 persons in 159 families) [8] . A value of P < 0.05 was considered to indicate statistical significance. The 95% confidence intervals (CI) for odds ratios
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Results

Clinical and laboratory data Gender, age and clinical symptoms of the patients
Clinical and laboratory data are shown in Table 1 . There was no gender bias in the patient population (eight males and eight females). Average patient age was 60.6 years. Four of the 16 patients exhibited pulmonary symptoms, such as pulmonary haemorrhage or atypical pneumonia-like shadows upon lung examination. Case 12 showed a peculiar clinical course by showing increases in anti-GBM antibody titres following pauci-immune-type crescentic glomerulonephritis combined with interstitial damage [9] .
Laboratory findings
Fourteen of the 16 patients presented with proteinuria and haematuria, whereas 2 patients showed anuria. As indicators of kidney function, average levels of blood urea nitrogen (BUN), serum creatinine and uric acid were 25.2 ± 16.1 mmol/L, 725 ± 530 µmol/L and 523 ± 202 µmol/L (mean ± SD), respectively. Immunofluorescence analyses were performed on 12 of the 13 kidney tissue specimens. Eleven of these 12 cases showed strong linear IgG deposition along the basement membrane. In the previously discussed case (case 12), a lack of IgG or other immunoglobulin deposition suggested that the patient had pauci-immune-type or interstitial nephritis; however, serum titres of anti-GBM antibody were elevated, even when the patient was treated with prednisolone therapy [9] . We included this peculiar case because we were able to analyse the relationship between the presence of anti-GBM antibodies and the HLA phenotype and genotype of the patient. In addition to IgG, a strong deposition of IgA was found in 2 of the 12 cases, and a weak deposition was observed in another patient.
Anti-GBM and anti-neutrophil cytoplasmic antibodies
Patient prognoses
Two patients died and nine patients required dialysis in the 3 months following treatment. Three patients responded to the initial treatment and recovered normal kidney function. Two patients responded to initial therapy, but their W. Kitagawa et al. 
Human leukocyte antigen
Therewas no relationship between HLA-A, HLA-B and the presence of anti-GBM antibodies ( Table 2 ). The phenotype frequency (PF) of DR15 was 93.8% (15/16). Seven patients were positive for DR4 (the PF was 43.8%), five were positive for DR9 (PF was 31.3%), two were positive for DR13 and two were positive for DR14. One of the 16 patients showed an absence of HLA-DR15; however, this patient had DR4 combined with DR9. For the HLA genotype, the allele frequency of HLA-DRB1 * 1501 was 46.4% (13/28). The allele frequency of HLA-DRB1 * 1501 was significantly different between patients with anti-GBM antibody-mediated diseases and Japanese controls (11.6%) (P < 0.001). Even though none of the patients had the HLA-DRB1 * 1502 allele, there was no difference in the frequency compared to Japanese controls (8.81%). The odds ratio for HLA-DRB1 * 1501 was 6.4 (95% CI: 2.4-16.5).
Discussion
The present study showed in patients with anti-GBM antibody-mediated disease that the PF of HLA-DR15 was 93.8% (15/16) , whereas the allele frequency of the HLA-DRB1
* 1501 was 46.6% (13/28). Previous reports revealed that the PF of HLA-DR15 in anti-GBM antibody-positive Caucasian patients (versus controls) was 63.9% versus 26.8% in Australia [2] , 92% versus 21.2% in France [3] , 91% versus 19.6% in the USA [4] and 79% versus 28% in the UK [7] . The odds ratios of the PF from these studies were 4. Previous work suggesting a relationship between HLA and kidney diseases showed that HLA-B8 and HLA-DR3 are strongly related to membranous nephropathy in Caucasian subjects [11] [12] [13] . Ogahara et al. [14] , however, noted a high PF of HLA-DR2 in Japanese patients with membranous nephropathy. Tomura et al. [15] confirmed the high prevalence of DR2 in these patients (74% versus 30.4% for patients versus controls; odds ratio: 6.5) and revealed that the PFs of DR4, DRw8 (DR8) and DRw9 (DR9) in the patients were significantly lower than those in controls (16% versus 39.2%, 4.0% versus 25.9% and 4.0% versus 26.6%, respectively). Hiki et al. [16] reported similar results for patients versus controls (DR4: 18.0% versus 41.4%; DRw9: 2.0% versus 23.0%). Although the present study revealed that the HLA-DRB1 * 1501 allele is prevalent among Japanese patients with anti-GBM antibody-mediated disease, it is still unclear whether HLA-DRB1 * 1501, HLA-DRB1 * 1502 or HLA-DRB1 * 1602 is associated with membranous nephropathy in the Japanese population.
A study conducted by the Ministry of Health, Labour and Welfare of Japan estimated that the number of new patients in Japan with anti-GBM antibody-mediated glomerulonephritis is 10-20 patients per year [17] . If DRB1 * 1501 by itself determined the occurrence of anti-GBM antibodymediated diseases, almost 12 million people in the Japanese
